Your browser doesn't support javascript.
loading
Localized tracheobronchial amyloidosis: A rare case presentation and tailored management approaches.
Arulanantham, Jonathan; Officer, Charlotte; O'Connor, Chelsie; Baillie, Tina; Bass, Simon; Williamson, Jonathan P; Carew, Alan.
Afiliación
  • Arulanantham J; Faculty of Medicine Health and Human Sciences Macquarie University Macquarie Park New South Wales Australia.
  • Officer C; Faculty of Medicine Health and Human Sciences Macquarie University Macquarie Park New South Wales Australia.
  • O'Connor C; GenesisCare, Radiation Oncology Macquarie University Hospital, Macquarie University Macquarie Park New South Wales Australia.
  • Baillie T; Anatomical Pathology Douglass Hanly Moir Macquarie Park New South Wales Australia.
  • Bass S; Medical Services Group South East Regional Hospital Bega New South Wales Australia.
  • Williamson JP; Faculty of Medicine Health and Human Sciences Macquarie University Macquarie Park New South Wales Australia.
  • Carew A; South Western Sydney Clinical School, Liverpool Hospital The University of New South Wales Sydney New South Wales Australia.
Respirol Case Rep ; 9(9): e0820, 2021 Sep.
Article en En | MEDLINE | ID: mdl-34401188
ABSTRACT
Localized tracheobronchial amyloidosis (TBA) is a rare manifestation of pulmonary amyloid disease, and can result in central airway obstruction. The nature of presentation is variable and there may be a delayed diagnosis. TBA has a variable prognosis and the most commonly used strategy for management is airway recanalization. Here, we describe the tailored management approach for a 64-year-old Caucasian female presenting with localized TBA of the left main bronchus. Pulmonary function testing, computed tomography and positron emission tomography results are detailed. Rigid bronchoscopy was utilized for diagnostic and therapeutic intervention, which involved debulking and stent insertion. Amyloid deposition and localized inflammation were identified through histopathology. Focal external beam radiation therapy was administered following multidisciplinary discussion and review of the literature, with no evidence of active disease at 6 months follow-up.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Respirol Case Rep Año: 2021 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Respirol Case Rep Año: 2021 Tipo del documento: Article